by Dr Robbins | Jan 23, 2013 | Headache Drugs
U.S. Specialty drugmaker Allergan has announced that it will buy MAP Pharmaceuticals, a purchase that will intensify Allergan’s presence in medicines for the treatment of adult migraines. Allergan manufactures Botox, which in the last few years has received...
by Dr Robbins | Nov 24, 2012 | Headache Drugs
Apparently the FDA has agreed to review the long-awaited drug application for MAPP Pharmaceutical’s inhaled form of dihydroergotamine(DHE), Levadex. DHE has been a very good migraine as needed….abortive…drug since 1945, with very few serious side...